Clinical malaria vaccine development.
SourceImmunology Letters, 122, 2, (2009), pp. 115-117
Article / Letter to editor
Display more detailsDisplay less details
SubjectN4i 3: Poverty-related infectious diseases; NCMLS 1: Infection and autoimmunity
Malaria is a major economic and public health problem in mainly sub-Saharan Africa. Globally 300-500 million new infections occur each year with 1-3 million fatal cases in particular young children. The most effective way to reduce disease and death from infectious diseases is to vaccinate susceptible populations. Increasing parasite resistance against available cheap anti-malarial drugs urges the need for development of malaria vaccines.
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.